期刊文献+

慢性乙型肝炎特殊患者抗病毒治疗专家共识 被引量:4

下载PDF
导出
摘要 近年来,慢性乙型肝炎(chronic hepatitis B,CHB)患者抗病毒治疗不断进展,一般患者的治疗逐渐趋于规范,而特殊人群患者由于循证医学证据相对不足、相关指南无统一的推荐意见等原因成为临床治疗的难点。
出处 《中国肝脏病杂志(电子版)》 CAS 2010年第1期44-51,共8页 Chinese Journal of Liver Diseases:Electronic Version
  • 相关文献

参考文献31

  • 1谢尧,范小玲,杨松.慢性丙型肝炎抗病毒治疗专家共识[J].中华实验和临床感染病杂志(电子版),2009,3(3):59-64. 被引量:67
  • 2王融冰,周桂琴,江宇泳,孙凤霞,吴云忠,孙静媛,孟培培,牛思盟.799例重型肝炎患者的临床病原学与实验室分析[J].中华肝脏病杂志,2006,14(9):655-657. 被引量:57
  • 3Seehofer D,Rayes N,Naumann U,et al.Preoperative antiviral treatment and postoperative prophylaxis in HBVDNA positive patients undergoing liver transplantation. Transplantation . 2001
  • 4Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. New England Journal of Medicine, The . 2005
  • 5Okuse C,Yotsuyanagi H,Yamada N,et al.Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clinical Nephrology . 2006
  • 6Deutsch M,Dourakis S,Manesis EK,et al.Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology . 1997
  • 7Nagano H,Monden M.FAIT(FU arterial infusion and interferon therapy)for hepatocellular carcinoma. Japanese Journal of Clinical Medicine . 2006
  • 8Sherman M.Strategies for managing coinfection with hepatitis B virus and HIV. Cleveland Clinic Journal of Medicine . 2009
  • 9Roque-Afonso AM,Feray C,Samuel D,et al.Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut . 2002
  • 10Nagamatsu H,Itano S,Nagaoka S,et al.Prophylactic lamivu-dine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma un-dergoing transhepatic arterial infusion chemotherapy. The American journal of Gastroenterology . 2004

二级参考文献6

共引文献117

同被引文献44

  • 1Zhou YZ,Jie YW,Nan Z.e e cacy of anti-viral therapy on hepa-titis B virus-associated glomerulonephritis:A systematic review and meta-analysis.Ann Hepatol,2011,10(2):165-173.
  • 2Zhang Y,Zhou J H,Yin X L,et al.Treatment of hepatitis B virus-as-sociated glomerulonephritis:a meta-analysis.World J Gastroenterol,2010,16(6):770-777.
  • 3Fabrizi F,Dixit V,Martin P.Meta-analysis:anti-viral therapy of hepatitis B virus-associated glomerulonephritis.Aliment Pharmacol er,2006,24(5):781-788.
  • 4Zhou JH.[Interpretation of the guidelines for diagnosis and treat-ment of HBV-associated glomerulonephritis].Zhonghua Er Ke Za Zhi,2010,48(8):596-598.
  • 5[Evidence-based guidelines for diagnosis and treatment of common renal diseases in children(for trial)(V):Guidelines for the diagnosis and treatment of HBV-associated glomerulonephritis].Zhonghua Er Ke Za Zhi,2010,48(8):592-595.
  • 6Lai F M,Tam J S,Li P K,et al.Replication of hepatitis B virus with cor-ticosteroid therapy in hepatitis B virus related membranous nephropa-thy.Virchows Arch A Pathol Anat Histopathol,1989,414(3):279-284.
  • 7Lai K N,Tam J S,Lin H J,et al.e therapeutic dilemma of the us-age of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia.Nephron,1990,54(1):12-17.
  • 8Sayarlioglu H,Erkoc R,Dogan E,et al.Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication.Ann Pharmacother,2005,39(3):573.
  • 9Johnson RJ,Couser WG.Hepatitis B infection and renal disease:clinical,immunopathogenetic and therapeutic considerations.Kid-ney Int,1990,37(2):663-676.
  • 10Lai K N,Lai FM.Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults.Kidney Int Suppl,1991,35:S40-S45.

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部